見前 隆洋TAKAHIRO MIMAE

Last Updated :2025/06/16

所属・職名
原爆放射線医科学研究所 助教
メールアドレス
tmimae@hiroshima-u.ac.jp

基本情報

主な職歴

  • 2012年04月01日, 2012年08月31日, 広島大学, 病院, 医科診療医
  • 2012年09月01日, 2015年03月31日, 広島大学, 原爆放射線医科学研究所放射線災害医療研究センター, 助教
  • 2015年04月, 2018年03月, Memorial Sloan Kettering Cancer Center, Research Fellow
  • 2018年04月01日, 2022年03月31日, 広島大学, 病院, 助教

学歴

  • 広島大学, 大学院医歯薬学総合研究科, 創生医科学専攻, 日本, 2008年04月, 2012年03月
  • 広島大学, 医学部, 医学科, 日本, 1997年04月, 2003年03月

学位

  • 博士(医学) (広島大学)

教育担当

  • 【学士課程】 医学部 : 医学科 : 医学プログラム
  • 【博士課程】 医系科学研究科 : 医歯薬学専攻 : 放射線医科学専門プログラム

担当主専攻プログラム

  • 医学プログラム

研究分野

  • 医歯薬学 / 外科系臨床医学 / 呼吸器外科学

教育活動

授業担当

  1. 2025年, 学部専門, 集中, 臨床実習入門プログラム
  2. 2025年, 学部専門, 集中, 臨床実習I
  3. 2025年, 学部専門, 集中, 臨床実習II
  4. 2025年, 学部専門, セメスター(前期), 外科学I

研究活動

学術論文(★は代表的な論文)

  1. Impact of postoperative pleurodesis on pulmonary function after lung segmentectomy, JTCVS OPEN, 5巻, pp. 110-118, 202103
  2. Role of ground-glass opacity in pure invasive and lepidic component in pure solid lung adenocarcinoma for predicting aggressiveness, JTCVS OPEN, 11巻, pp. 300-316, 202209
  3. Comparative oncological features of centrally and peripherally located small-sized radiologically solid-dominant non-small-cell lung cancer, EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 67巻, 4号, 202504
  4. Discrepancy Between Radiological and Pathological Tumor Size in Early-Stage NonSmall Cell Lung Cancer: A Multicenter Study, SEMINARS IN THORACIC AND CARDIOVASCULAR SURGERY, 36巻, 2号, 2022
  5. Guidelines for preoperative pulmonary function assessment in patients with lung cancer who will undergo surgery (The Japanese Association for Chest Surgery), GENERAL THORACIC AND CARDIOVASCULAR SURGERY, 73巻, 6号, pp. 385-404, 202506
  6. Role of 18F-fluorodeoxyglucose accumulation in radiological ground-glass opacity of non-small cell lung cancer, JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 55巻, 4号, pp. 391-398, 202504
  7. Segmentectomy versus lobectomy in younger patients with early-stage non-small cell lung cancer, INTERDISCIPLINARY CARDIOVASCULAR AND THORACIC SURGERY, 40巻, 2号, 20250303
  8. Risk Factors for Locoregional Relapse After Segmentectomy: Supplementary Analysis of the JCOG0802/WJOG4607L Trial, JOURNAL OF THORACIC ONCOLOGY, 20巻, 2号, pp. 157-166, 202502
  9. Role of guanylate-binding protein 1 in the proliferation of invasive lung adenocarcinoma cells, FRONTIERS IN ONCOLOGY, 15巻, 20250213
  10. Feasibility and comparative prognosis of segmentectomy versus lobectomy in centrally located small and solid dominant cN0 non-small cell lung cancer, JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 169巻, 2号, 202502
  11. Prediction of Pathologic Complete Response in Esophageal Squamous Cell Carcinoma Using Preoperative Serum Small Ribonucleic Acid Obtained After Neoadjuvant Chemoradiotherapy, ANNALS OF SURGICAL ONCOLOGY, 32巻, 1号, pp. 570-580, 202501
  12. Prediction of Pathologic Complete Response in Esophageal Squamous Cell Carcinoma Using Preoperative Serum Small Ribonucleic Acid Obtained After Neoadjuvant Chemoradiotherapy, ANNALS OF SURGICAL ONCOLOGY, 32巻, 1号, pp. 570-580, 202501
  13. Mitochondrial Metabolism as a Potential Novel Therapeutic Target for Lung Adenocarcinoma, ANTICANCER RESEARCH, 44巻, 12号, pp. 5241-5252, 202412
  14. Omitting Lymph Node Dissection for Small Ground-Glass Opacity-Dominant Tumors, ANNALS OF THORACIC SURGERY, 119巻, 1号, pp. 192-198, 202501
  15. Postoperative pulmonary function of patients with lung cancer and interstitial lung abnormalities, GENERAL THORACIC AND CARDIOVASCULAR SURGERY, 72巻, 12号, pp. 786-795, 20241201
  16. The Lung Cancer Surgical Study Group of the Japan Clinical Oncology Group: outstanding contribution and entering a new phase, JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 54巻, 12号, pp. 1237-1243, 20240819
  17. Updated review of perioperative treatment for non-small-cell lung cancer in the new era of immune checkpoint inhibitors: past, present, and future, JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 54巻, 12号, pp. 1244-1253, 20240820
  18. Lymph node dissection in small peripheral lung cancer: Supplemental analysis of JCOG0802/WJOG4607L, JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 168巻, 3号, 202409
  19. Lymph node dissection in small peripheral lung cancer: Supplemental analysis of JCOG0802/WJOG4607L, JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 168巻, 3号, 202409
  20. ASO Author Reflections: How Does Emphysema Contribute to Poor Prognosis After Lung Cancer Surgery?, ANNALS OF SURGICAL ONCOLOGY, 31巻, 7号, pp. 4323-4324, 202407
  21. The Role of Emphysema on Postoperative Prognosis in Early-Stage Nonsmall Cell Lung Cancer, ANNALS OF SURGICAL ONCOLOGY, 31巻, 8号, pp. 5055-5063, 202408
  22. Sublobar Resection in Early Non-Small Cell Lung Cancer With Epidermal Growth Factor Receptor Mutant, ANNALS OF THORACIC SURGERY, 118巻, 2号, pp. 395-401, 202408
  23. Clinical Signif icance of Preserving Pulmonary Function After Lung Resection in Early-Stage Non-Small-Cell Lung Cancer, CLINICAL LUNG CANCER, 25巻, 4号, 202406
  24. Differences in postoperative prognosis between early-stage lung adenocarcinoma and squamous cell carcinoma, JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 54巻, 7号, pp. 813-821, 20240427
  25. Risk Factors for Recurrence of Stage I Epidermal Growth Factor Receptor Mutated Lung Adenocarcinoma, ANNALS OF THORACIC SURGERY, 117巻, 4号, 202404
  26. Wedge resection is an acceptable treatment option for radiologically low-grade lung cancer with solid predominance, INTERDISCIPLINARY CARDIOVASCULAR AND THORACIC SURGERY, 36巻, 1号, 20230109
  27. Tumor distance from the mediastinum predicts N2 upstaging in clinical stage I lower-lobe non-small cell lung cancer, JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 167巻, 2号, 202402
  28. Rare but clinically important salivary gland-type tumor of the lung: A review, JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 54巻, 2号, pp. 121-128, 20240207
  29. A multicenter propensity score-matched analysis of lymphadenectomy in N1-positve lung cancer, JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 53巻, 12号, pp. 1183-1190, 20231207
  30. Hypoxia-inducible factor 1ホア modulates interstitial pneumonia-mediated lung cancer progression, JOURNAL OF TRANSLATIONAL MEDICINE, 21巻, 1号, 20231127
  31. Risk factors for loss of pulmonary function after wedge resection for peripheral ground-glass opacity dominant lung cancer, EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 64巻, 6号, 20231201
  32. Effectiveness of pleurodesis for postoperative air leaks after lung resection, JOURNAL OF CARDIOTHORACIC SURGERY, 19巻, 1号, 20240102
  33. Anatomical segmentectomy versus wedge resection for small (≤2 cm) peripheral non -small cell lung cancer in 80 or more aged elderly patients: a randomized phase Ill study (JCOG2109, AWESOME), JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 53巻, 11号, pp. 1077-1081, 20231105
  34. Asian Perspective on Lung Cancer Screening, THORACIC SURGERY CLINICS, 33巻, 4号, pp. 385-400, 202311
  35. Prediction of Unexpected N2 Disease Associated With Clinical T1-2N0-1M0 Non-Small-Cell Lung Cancer., Clinical lung cancer, 22巻, 2号, 2021
  36. ASO Author Reflections: Is Wedge Resection Optimal for Octogenarians with Early-Stage Non-Small-Cell Lung Cancer Compared with Lobectomy/Segmentectomy?, Annals of surgical oncology, 28巻, 12号, 2021
  37. Survival of Octogenarians with Early-Stage Non-small Cell Lung Cancer is Comparable Between Wedge Resection and Lobectomy/Segmentectomy: JACS1303., Annals of surgical oncology, 28巻, 12号, 2021
  38. Predictive role of circulatory HMGB1 in postoperative acute exacerbation of interstitial lung disease in lung cancer patients., Scientific reports, 11巻, 1号, 2021
  39. Prognostic role of interstitial pneumonia with or without emphysema in patients with clinical stage I lung cancer., Japanese journal of clinical oncology, 51巻, 7号, 2021
  40. Complex Segmentectomy for Hypermetabolic Clinical Stage IA Non-Small Cell Lung Cancer., The Annals of thoracic surgery, 113巻, 4号, 2022
  41. Serum S100 calcium-binding protein A4 as a novel predictive marker of acute exacerbation of interstitial pneumonia after surgery for lung cancer., BMC pulmonary medicine, 21巻, 1号, 2021
  42. The impact of pathological lymph node metastasis with lymphatic invasion on the survival of patients with clinically node-negative non-small cell lung cancer: A multicenter study., Lung cancer (Amsterdam, Netherlands), 158巻, 2021
  43. Role of Soluble Receptor for Advanced Glycation End Products in Postoperative Fibrotic Lung Injury., The Annals of thoracic surgery, 113巻, 5号, 2022
  44. Systematic Versus Lobe-Specific Mediastinal Lymphadenectomy for Hypermetabolic Lung Cancer., Annals of surgical oncology, 28巻, 12号, 2021
  45. Postoperative Pulmonary Function After Complex Segmentectomy., Annals of surgical oncology, 28巻, 13号, 2021
  46. Utility of Newly Proposed Grading System From International Association for the Study of Lung Cancer for Invasive Lung Adenocarcinoma., JTO clinical and research reports, 2巻, 2号, 2021
  47. Segmentectomy versus lobectomy for solid predominant cN0 lung cancer: analysis using visual evaluation of positron emission tomography., European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery, 61巻, 2号, 2022
  48. Segmentectomy versus wedge resection for radiological solid predominant and low metabolic non-small cell lung cancer., Interactive cardiovascular and thoracic surgery, 34巻, 5号, 2022
  49. Interstitial pneumonia and advanced age negatively influence postoperative pulmonary function., Interactive cardiovascular and thoracic surgery, 34巻, 5号, 2022
  50. Oncological outcome of segmentectomy for early-stage non-small-cell lung cancer with invasive characteristics: a multicentre study., European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery, 62巻, 2号, 2022
  51. The prognostic impact of the ground-glass opacity component in nearly pure-solid stage IA non-small-cell lung cancer., European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery, 2022
  52. Sublobar Resection for Non-Small Cell Lung Cancer in Octogenarians: A Prospective, Multicenter Study, ANNALS OF THORACIC SURGERY, 116巻, 3号, pp. 543-551, 202309
  53. Segmentectomy for ground-glass-dominant lung cancer with a tumour diameter of 3 cm or less including ground- glass opacity (JCOG1211): a multicentre, single-arm, confirmatory, phase 3 trial, LANCET RESPIRATORY MEDICINE, 11巻, 6号, pp. 540-549, 202306
  54. Segmentectomy for cancer control in radiologically pure-solid clinical stage IA3 lung cancer, INTERDISCIPLINARY CARDIOVASCULAR AND THORACIC SURGERY, 37巻, 3号, 20230902
  55. Extracellular vesicle-associated microRNA signatures related to lymphovascular invasion in early-stage lung adenocarcinoma, SCIENTIFIC REPORTS, 13巻, 1号, 20230424
  56. Extracellular vesicle-associated microRNA signatures related to lymphovascular invasion in early-stage lung adenocarcinoma, SCIENTIFIC REPORTS, 13巻, 1号, 20230324
  57. Feasibility of repeated ipsilateral anatomical pulmonary resection, SURGERY TODAY, 53巻, 3号, pp. 379-385, 202303
  58. Tumour location predicts occult N1 nodal metastasis in clinical stage I non-small-cell lung cancer, EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 63巻, 2号, 20230203
  59. Segmentectomy preserves better immune-nutritional status than lobectomy in patients with early-stage lung cancer, EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 63巻, 2号, 20230203
  60. Usefulness of serum S100A4 and positron-emission tomography on lung cancer accompanied by interstitial pneumonia, THORACIC CANCER, 14巻, 4号, pp. 381-388, 202302
  61. Impact of the amount of preoperative erector spinae muscle in stage I non-small-cell lung cancer, EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 63巻, 1号, 20221202
  62. The intersegmental pulmonary vein is not always located on the intersegmental plane of the lung: Evaluation with 3-dimensional volume-rendering image reconstruction, JTCVS TECHNIQUES, 16巻, pp. 132-138, 202212
  63. Segmentectomy for clinically early-stage primary squamous cell carcinoma of the lung, THORACIC CANCER, 13巻, 24号, pp. 3477-3485, 202212
  64. The prognostic impact of the ground-glass opacity component in nearly pure-solid stage IA non-small-cell lung cancer, EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 62巻, 3号, 20220803
  65. Commentary: Segmentectomy as a standard surgery, a new era in small sized, peripheral, non-small cell lung cancer., JTCVS techniques, 12巻, 2022
  66. A Multicenter Study of Complex Segmentectomy Versus Wedge Resection in Clinical Stage 0-IA Non-Small Cell Lung Cancer., Clinical lung cancer, 23巻, 5号, 2022
  67. Psychological states regarding adjuvant chemotherapy in patients with non-small cell lung cancer., Cancer treatment and research communications, 32巻, 2022
  68. Complications and Survival After Lung Cancer Resection in Interstitial Lung Disease., The Annals of thoracic surgery, 2022
  69. Possible Therapeutic Utility of anti-Cell Adhesion Molecule 1 Antibodies for Malignant Pleural Mesothelioma., Frontiers in cell and developmental biology, 10巻, 2022
  70. Oncological outcome of segmentectomy for early-stage non-small-cell lung cancer with invasive characteristics: a multicentre study, EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 62巻, 2号, 20220711
  71. Complex Segmentectomy for Hypermetabolic Clinical Stage IA Non-Small Cell Lung Cancer, ANNALS OF THORACIC SURGERY, 113巻, 4号, pp. 1317-1324, 202204
  72. ASO Author Reflections: Is Wedge Resection Optimal for Octogenarians with Early-Stage Non-Small-Cell Lung Cancer Compared with Lobectomy/Segmentectomy?, ANNALS OF SURGICAL ONCOLOGY, 28巻, 12号, pp. 7228-7229, 202111
  73. Role of Soluble Receptor for Advanced Glycation End Products in Postoperative Fibrotic Lung Injury, ANNALS OF THORACIC SURGERY, 113巻, 5号, pp. 1617-1623, 202205
  74. Interstitial pneumonia and advanced age negatively influence postoperative pulmonary function, INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY, 34巻, 5号, pp. 753-759, 20220502
  75. Segmentectomy versus wedge resection for radiological solid predominant and low metabolic non-small cell lung cancer, INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY, 34巻, 5号, pp. 814-821, 20220502
  76. Segmentectomy versus lobectomy for solid predominant cN0 lung cancer: analysis using visual evaluation of positron emission tomography, EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 61巻, 2号, pp. 279-286, 20220124
  77. Upregulation of Notch2 and Six1 Is Associated with Progression of Early- Stage Lung Adenocarcinoma and a More Aggressive Phenotype at Advanced Stages, CLINICAL CANCER RESEARCH, 18巻, 4号, pp. 945-955, 20120215
  78. Novel application for pseudopodia proteomics using excimer laser ablation and two-dimensional difference gel electrophoresis, LABORATORY INVESTIGATION, 92巻, 9号, pp. 1374-1385, 201209
  79. Cathepsin D as a potential prognostic marker for lung adenocarcinoma, PATHOLOGY RESEARCH AND PRACTICE, 208巻, 9号, pp. 534-540, 2012
  80. Protein expression and gene copy number changes of receptor tyrosine kinase in thymomas and thymic carcinomas, ANNALS OF ONCOLOGY, 23巻, 12号, pp. 3129-3137, 201212
  81. The prognostic role of pathologic invasive component size, excluding lepidic growth, in stage I lung adenocarcinoma, JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 146巻, 3号, pp. 580-585, 201309
  82. Increased ectodomain shedding of lung epithelial cell adhesion molecule 1 as a cause of increased alveolar cell apoptosis in emphysema, THORAX, 69巻, 3号, pp. 223-231, 201403
  83. alpha-Parvin, a pseudopodial constituent, promotes cell motility and is associated with lymph node metastasis of lobular breast carcinoma, BREAST CANCER RESEARCH AND TREATMENT, 144巻, 1号, pp. 59-69, 201402
  84. Role of lymphatic invasion in the prognosis of patients with clinical node-negative and pathologic node-positive lung adenocarcinoma, JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 147巻, 6号, pp. 1820-1826, 201406
  85. Prediction for prognosis of resected pT1a-lbN0M0 adenocarcinoma based on tumor size and histological status: Relationship of TNM and IASLC/ATS/ERS classifications, LUNG CANCER, 85巻, 2号, pp. 270-275, 201408
  86. Role of Positron Emission Tomography/Computed Tomography Findings for Adjuvant Chemotherapy Indications in Stage T1b-2aN0M0 Lung Adenocarcinoma, ANNALS OF THORACIC SURGERY, 98巻, 2号, pp. 417-423, 201408
  87. Prognosis of Lung Cancer Patients with a Past History of Colorectal Cancer, JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 44巻, 11号, pp. 1088-1095, 201411
  88. Paclitaxel followed by FEC 療法による乳癌術前化学療法の臨床病理学的評価, 日本臨床外科学会雑誌 = The journal of the Japan Surgical Association, 66巻, 5号, pp. 990-994, 20050525
  89. 胃静脈瘤出血を契機に発見された膵神経内分泌癌の1例, 日本臨床外科学会雑誌 = The journal of the Japan Surgical Association, 69巻, 8号, pp. 2108-2113, 20080825
  90. 膵癌根治手術における術中放射線照射の効果(肝・胆・膵37, 第60回日本消化器外科学会総会), 日本消化器外科学会雑誌, 38巻, 7号, 20050701
  91. 43.当院における大細胞神経内分泌癌症例(第46回日本肺癌学会中国・四国支部会), 肺癌, 47巻, 4号, 20070820
  92. 74.同時性両側肺がんの2手術例(第46回日本肺癌学会中国・四国支部会), 肺癌, 47巻, 4号, 20070820
  93. 幽門側胃切除術後Roux stasis syndromeの検討, 日本消化器外科学会雑誌, 41巻, 8号, pp. 1551-1556, 20080801
  94. 切除された術前未確診例の検討 : CT検診の臨床診断への影響, 日本呼吸器外科学会雑誌 = The journal of the Japanese Association for Chest Surgery, 22巻, 7号, pp. 992-996, 20081115
  95. YT-12-3(YRA) 臨床病期1A期肺腺癌におけるリンパ管浸潤の意義(YT Young Researcher Award & Traveler's Grant,第113回日本外科学会定期学術集会), 日本外科学会雑誌, 114巻, 2号, 20130305
  96. YT-12-5(YRA) 病理病期I期の肺腺癌症例においては浸潤径がT因子を反映する(YT Young Researcher Award & Traveler's Grant,第113回日本外科学会定期学術集会), 日本外科学会雑誌, 114巻, 2号, 20130305
  97. PS-023-3 臨床病期stageIA肺腺癌における術前補助療法適用の可能性 : 術後遠隔転移再発リスク因子の検討(PS ポスターセッション,第113回日本外科学会定期学術集会), 日本外科学会雑誌, 114巻, 2号, 20130305
  98. PS-023-5 より安全な縮小手術のために : リンパ節転移予測因子としての画像的浸潤径とSUVmaxの有用性(PS ポスターセッション,第113回日本外科学会定期学術集会), 日本外科学会雑誌, 114巻, 2号, 20130305
  99. VSY-6-1 原発性肺癌に対するロボット手術の初期経験(VSY-6 ビデオシンポジウム(6)Robotic Surgeryによる呼吸器外科施術,第114回日本外科学会定期学術集会), 日本外科学会雑誌, 115巻, 2号, 20140305
  100. PS-029-8 肺気腫発症の新規機序 : Cell adhesion molecule 1のshedding亢進による細胞内ドメインの産生(PS-029 肺 基礎-1,ポスターセッション,第114回日本外科学会定期学術集会), 日本外科学会雑誌, 115巻, 2号, 20140305
  101. PS-106-8 シスプラチン誘発性の食思不振とQOL低下に対する六君子湯投与の意義(PS-106 肺 合併症-2・その他,ポスターセッション,第114回日本外科学会定期学術集会), 日本外科学会雑誌, 115巻, 2号, 20140305
  102. Paclitaxel followed by FEC療法による乳癌術前化学療法の臨床病理学的評価, 日本臨床外科学会雑誌, 66巻, 5号, pp. 990-994, 2005
  103. 幽門側胃切除術後Roux stasis syndromeの検討, 日本消化器外科学会雑誌, 41巻, 8号, pp. 1551-1556, 2008
  104. 胃静脈瘤出血を契機に発見された膵神経内分泌癌の1例, 日本臨床外科学会雑誌, 69巻, 8号, pp. 2108-2113, 2008
  105. [A clinical study of endoscopic local coagulation therapy for hepatocellular carcinoma (HCC)]., Gan to kagaku ryoho. Cancer & chemotherapy, 32巻, 11号, 2005
  106. [A case of recurrent gastric cancer with improvement of obstructive symptoms caused by carcinomatous peritonitis and prolonged survival by chemotherapy with combined use of Paclitaxel and 5-FU]., Gan to kagaku ryoho. Cancer & chemotherapy, 33巻, 2号, 2006
  107. Esophagectomy via left thoracotomy for esophageal cancer with situs inversus totalis: report of a case., Surgery today, 38巻, 11号, 2008
  108. Advantage of absorbable suture material for pulmonary artery ligation., General thoracic and cardiovascular surgery, 58巻, 10号, 2010
  109. Upregulation of notch2 and six1 is associated with progression of early-stage lung adenocarcinoma and a more aggressive phenotype at advanced stages., Clinical cancer research : an official journal of the American Association for Cancer Research, 18巻, 4号, 2012
  110. c-MET/phospho-MET protein expression and MET gene copy number in non-small cell lung carcinomas., Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 7巻, 2号, 2012
  111. Novel application for pseudopodia proteomics using excimer laser ablation and two-dimensional difference gel electrophoresis., Laboratory investigation; a journal of technical methods and pathology, 92巻, 9号, 2012
  112. Cathepsin D as a potential prognostic marker for lung adenocarcinoma., Pathology, research and practice, 208巻, 9号, 2012
  113. Increased ectodomain shedding of lung epithelial cell adhesion molecule 1 as a cause of increased alveolar cell apoptosis in emphysema., Thorax, 69巻, 3号, 2014
  114. α-Parvin, a pseudopodial constituent, promotes cell motility and is associated with lymph node metastasis of lobular breast carcinoma., Breast cancer research and treatment, 144巻, 1号, 2014
  115. Role of lymphatic invasion in the prognosis of patients with clinical node-negative and pathologic node-positive lung adenocarcinoma., The Journal of thoracic and cardiovascular surgery, 147巻, 6号, 2014
  116. Segmentectomy versus lobectomy for clinical stage IA lung adenocarcinoma., Annals of cardiothoracic surgery, 3巻, 2号, 2014
  117. Role of positron emission tomography/computed tomography findings for adjuvant chemotherapy indications in stage T1b-2aN0M0 lung adenocarcinoma., The Annals of thoracic surgery, 98巻, 2号, 2014
  118. Prediction for prognosis of resected pT1a-1bN0M0 adenocarcinoma based on tumor size and histological status: relationship of TNM and IASLC/ATS/ERS classifications., Lung cancer (Amsterdam, Netherlands), 85巻, 2号, 2014
  119. Surgical outcomes of non-small-cell lung carcinoma in patients previously treated for gastric cancer., European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery, 47巻, 4号, 2015
  120. Prognosis of lung cancer patients with a past history of colorectal cancer., Japanese journal of clinical oncology, 44巻, 11号, 2014
  121. Reply to the editor., The Journal of thoracic and cardiovascular surgery, 148巻, 4号, 2014
  122. A novel approach to pseudopodia proteomics: excimer laser etching, two-dimensional difference gel electrophoresis, and confocal imaging., Protocol exchange, 2014巻, 2014
  123. New challenges in pseudopodial proteomics by a laser-assisted cell etching technique., Biochimica et biophysica acta, 1854巻, 6号, 2015
  124. Comparison of malignant grade between pure and partially invasive types of early lung adenocarcinoma., The Annals of thoracic surgery, 99巻, 3号, 2015
  125. What are the radiologic findings predictive of indolent lung adenocarcinoma?, Japanese journal of clinical oncology, 45巻, 4号, 2015
  126. Histologic changes associated with the use of fibrinogen- and thrombin-impregnated collagen in the prevention of pulmonary air leakage., The Journal of thoracic and cardiovascular surgery, 149巻, 4号, 2015
  127. Negative prognostic influence of micropapillary pattern in stage IA lung adenocarcinoma., European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery, 49巻, 1号, 2016
  128. Surgical Outcomes of Lung Cancer in Patients with Combined Pulmonary Fibrosis and Emphysema., Annals of surgical oncology, 22 Suppl 3巻, 2015
  129. Radiologic findings to predict low-grade malignant tumour among clinical T1bN0 lung adenocarcinomas: lessons from histological subtypes., Japanese journal of clinical oncology, 45巻, 8号, 2015
  130. Increased ectodomain shedding of cell adhesion molecule 1 as a cause of type II alveolar epithelial cell apoptosis in patients with idiopathic interstitial pneumonia., Respiratory research, 16巻, 2015
  131. The intracellular domain of cell adhesion molecule 1 is present in emphysematous lungs and induces lung epithelial cell apoptosis., Journal of biomedical science, 22巻, 2015
  132. The Difference in Maximum Standardized Uptake Value among Lung Adenocarcinomas Located at the Upper and Lower Zone on PET/CT., Respiration; international review of thoracic diseases, 90巻, 4号, 2015
  133. Impact of Lepidic Component Occupancy on Effects of Adjuvant Chemotherapy for Lung Adenocarcinoma., The Annals of thoracic surgery, 100巻, 6号, 2015
  134. Prognostic value of the new IASLC/ATS/ERS classification of clinical stage IA lung adenocarcinoma., Lung cancer (Amsterdam, Netherlands), 90巻, 2号, 2015
  135. Association between [18F]-fluoro-2-deoxyglucose uptake and expressions of hypoxia-induced factor 1α and glucose transporter 1 in non-small cell lung cancer., Japanese journal of clinical oncology, 45巻, 12号, 2015
  136. Application of Lepidic Component Predominance to Adjuvant Chemotherapy with Oral Fluoropyrimidines for Stage I Lung Adenocarcinoma., Clinical lung cancer, 17巻, 5号, 2016
  137. Prognostic Role of Subtype Classification in Small-Sized Pathologic N0 Invasive Lung Adenocarcinoma., The Annals of thoracic surgery, 102巻, 5号, 2016
  138. Severity of lung fibrosis affects early surgical outcomes of lung cancer among patients with combined pulmonary fibrosis and emphysema., Medicine, 95巻, 29号, 2016
  139. Feasibility and efficacy of salvage lung resection after definitive chemoradiation therapy for Stage III non-small-cell lung cancer., Interactive cardiovascular and thoracic surgery, 23巻, 6号, 2016
  140. Prognostic significance of vascular invasion in intermediate-grade subtype of lung adenocarcinoma., Japanese journal of clinical oncology, 2016
  141. Integrin-α10 Dependency Identifies RAC and RICTOR as Therapeutic Targets in High-Grade Myxofibrosarcoma., Cancer discovery, 6巻, 10号, 2016
  142. Is cancer history really an exclusion criterion for clinical trial of lung cancer? Influence of gastrointestinal tract cancer history on the outcomes of lung cancer surgery., Japanese journal of clinical oncology, 47巻, 2号, 2017
  143. Is cancer history really an exclusion criterion for clinical trial of lung cancer? Influence of gastrointestinal tract cancer history on the outcomes of lung cancer surgery., Japanese journal of clinical oncology, 47巻, 2号, 2017
  144. 今月の臨床 肺大細胞神経内分泌癌の手術例, 胸部外科, 62巻, 6号, pp. 442-445, 200906
  145. 2年間経過観察後に切除した膵併存腫瘍の1例, 胆と膵, 27巻, pp. 601-605, 2006
  146. [Correlations between hormonal receptor and HER2 status or nuclear grades and response rate in breast cancer treated with neoadjuvant chemotherapy of docetaxel alone]., Gan to kagaku ryoho. Cancer & chemotherapy, 36巻, 4号, 2009
  147. Steroid receptor expression in thymomas and thymic carcinomas., Cancer, 117巻, 19号, 2011
  148. Insulin-like growth factor-1 receptor protein expression and gene copy number alterations in non-small cell lung carcinomas., Human pathology, 44巻, 6号, 2013
  149. The prognostic role of pathologic invasive component size, excluding lepidic growth, in stage I lung adenocarcinoma., The Journal of thoracic and cardiovascular surgery, 146巻, 3号, 2013
  150. The differences in histological changes among pulmonary vessels divided with an energy device, INTERACTIVE CARDIOVASCULAR AND THORACIC SURGERY, 27巻, 3号, pp. 372-378, 201809
  151. Surgical Outcomes of Complex Versus Simple Segmentectomy for Stage I Non-Small Cell Lung Cancer, ANNALS OF THORACIC SURGERY, 107巻, 4号, pp. 1032-1039, 201904
  152. Breast cancer cell motility is promoted by 14-3-3 gamma, BREAST CANCER, 26巻, 5号, pp. 581-593, 201909
  153. Postoperative Recurrence and Survival After Segmentectomy for Clinical Stage 0 or IA Lung Cancer, CLINICAL LUNG CANCER, 20巻, 5号, pp. 397-+, 201909
  154. Guanylate binding protein 1 (GBP-1) promotes cell motility and invasiveness of lung adenocarcinoma, BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 518巻, 2号, pp. 266-272, 20191015
  155. Complex segmentectomy in the treatment of stage IA non-small-cell lung cancer, EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 57巻, 1号, pp. 114-121, 202001
  156. Wedge resection versus segmentectomy in patients with stage I non-small-cell lung cancer unfit for lobectomy, JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 49巻, 12号, pp. 1134-1142, 201912
  157. Albumin-globulin ratio is a predictive biomarker of antitumor effect of anti-PD-1 antibody in patients with non-small cell lung cancer, INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 25巻, 1号, pp. 74-81, 202001
  158. Albumin-globulin ratio is a predictive biomarker of antitumor effect of anti-PD-1 antibody in patients with non-small cell lung cancer, INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 25巻, 1号, pp. 74-81, 202001
  159. Prospective, randomized, cross-over pilot study of the effects of Rikkunshito, a Japanese traditional herbal medicine, on anorexia and plasma-acylated ghrelin levels in lung cancer patients undergoing cisplatin-based chemotherapy, INVESTIGATIONAL NEW DRUGS, 38巻, 2号, pp. 485-492, 202004
  160. Predicting Severe Postoperative Complication in Patients With Lung Cancer and Interstitial Pneumonia, ANNALS OF THORACIC SURGERY, 109巻, 4号, pp. 1054-1060, 202004
  161. Solid Tumor Size of 2 cm Divides Outcomes of Patients With Mixed Ground Glass Opacity Lung Tumors, ANNALS OF THORACIC SURGERY, 109巻, 5号, pp. 1530-1536, 202005
  162. Initial experience of robotic anatomical segmentectomy for non-small cell lung cancer, JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 50巻, 4号, pp. 440-445, 202004
  163. LPrognostic Impact of Programmed Death-ligand 1 and Surrounding Immune Status on Stage I Lung Cancer, CLINICAL LUNG CANCER, 21巻, 4号, pp. E302-E314, 202007
  164. Are segmentectomy and lobectomy comparable in terms of curative intent for early stage non-small cell lung cancer?, GENERAL THORACIC AND CARDIOVASCULAR SURGERY, 68巻, 7号, pp. 703-706, 202007
  165. Prediction of Lymph Node Metastasis Using Semiquantitative Evaluation of PET for Lung Adenocarcinoma, ANNALS OF THORACIC SURGERY, 110巻, 3号, pp. 1036-1042, 202009
  166. Comparing Segmentectomy and Lobectomy for Clinical Stage IA Solid-dominant Lung Cancer Measuring 2.1 to 3 cm, CLINICAL LUNG CANCER, 21巻, 6号, pp. E528-E538, 202011
  167. Wedge resection as an alternative treatment for octogenarian and older patients with early-stage non-small-cell lung cancer, JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 50巻, 9号, pp. 1051-1057, 202009
  168. Clinical features and prognosis of clinical N0 non-small cell lung cancer exceeding 30 mm, JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 50巻, 11号, pp. 1306-1312, 202011
  169. Prognosis of segmentectomy and lobectomy for radiologically aggressive small-sized lung cancer, EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 58巻, 6号, pp. 1245-1253, 202012
  170. Patient Selection of Sublobar Resection Using Visual Evaluation of Positron-Emission Tomography (PET) for Early-Stage Lung Adenocarcinoma, ANNALS OF SURGICAL ONCOLOGY, 28巻, 4号, pp. 2068-2075, 202104
  171. Preoperative nivolumab to evaluate pathological response in patients with stage I non-small cell lung cancer: a study protocol of phase II trial (POTENTIAL), BMJ OPEN, 11巻, 3号, 2021
  172. Oncologic Outcomes of Complex Segmentectomy: A Multicenter Propensity Score-Matched Analysis, ANNALS OF THORACIC SURGERY, 111巻, 3号, pp. 1044-1051, 202103
  173. Prediction of Unexpected N2 Disease Associated With Clinical T1-2N0-1M0 Non-Small-Cell Lung Cancer, CLINICAL LUNG CANCER, 22巻, 2号, pp. 120-+, 202103
  174. Surgical Procedure Selection for Stage I Lung Cancer: Complex Segmentectomy versus Wedge Resection, CLINICAL LUNG CANCER, 22巻, 2号, pp. E224-E233, 202103
  175. Appropriate Extent of Lymphadenectomy in Segmentectomy: A Multicenter Study, JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 51巻, 3号, pp. 451-458, 202103
  176. Predictive role of circulatory HMGB1 in postoperative acute exacerbation of interstitial lung disease in lung cancer patients, SCIENTIFIC REPORTS, 11巻, 1号, 20210512
  177. Long-Term Outcomes After Sublobar Resection Versus Lobectomy in Patients With Clinical Stage IA Lung Adenocarcinoma Meeting the Node-Negative Criteria Defined by High-Resolution Computed Tomography and [F-18]-Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography, CLINICAL LUNG CANCER, 22巻, 3号, pp. E431-E437, 202105
  178. Serum S100 calcium-binding protein A4 as a novel predictive marker of acute exacerbation of interstitial pneumonia after surgery for lung cancer, BMC PULMONARY MEDICINE, 21巻, 1号, 20210602
  179. Prognostic role of interstitial pneumonia with or without emphysema in patients with clinical stage I lung cancer, JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 51巻, 7号, pp. 1123-1131, 202107
  180. Prediction of Acute Exacerbation of Interstitial Pneumonia Using Visual Evaluation of PET, ANNALS OF THORACIC SURGERY, 112巻, 1号, pp. 264-270, 202107
  181. The impact of pathological lymph node metastasis with lymphatic invasion on the survival of patients with clinically node-negative non-small cell lung cancer: A multicenter study, LUNG CANCER, 158巻, pp. 9-14, 202108
  182. Survival of Octogenarians with Early-Stage Non-small Cell Lung Cancer is Comparable Between Wedge Resection and Lobectomy/Segmentectomy: JACS1303, ANNALS OF SURGICAL ONCOLOGY, 28巻, 12号, pp. 7219-7227, 202111
  183. Systematic Versus Lobe-Specific Mediastinal Lymphadenectomy for Hypermetabolic Lung Cancer, ANNALS OF SURGICAL ONCOLOGY, 28巻, 12号, pp. 7162-7171, 202111
  184. Risk of death due to other causes is lower among octogenarians with non-small cell lung cancer after wedge resection than lobectomy/segmentectomy, JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 51巻, 10号, pp. 1561-1569, 202110
  185. Postoperative Pulmonary Function After Complex Segmentectomy, ANNALS OF SURGICAL ONCOLOGY, 28巻, 13号, pp. 8347-8355, 202112

著書等出版物

  1. 2009年06月, 今月の臨床 肺大細胞神経内分泌癌の手術例, 胸部外科 / 南江堂 [編], 見前 隆洋;山下 素弘;前田 愛 他;前田 愛
  2. 2008年, 切除された術前未確診例の検討―CT検診の臨床診断への影響―:—CT検診の臨床診断への影響—, 日本呼吸器外科学会雑誌, 沢田 茂樹;小森 栄作;末久 弘;豊崎 良一;見前 隆洋;山下 素弘
  3. 2005年, Paclitaxel followed by FEC療法による乳癌術前化学療法の臨床病理学的評価, 日本臨床外科学会雑誌, 桧垣 健二;守田 陽土;久保 陽司;見前 隆洋;丁田 泰宏;梅岡 達生;原野 雅生;佐々木 寛;二宮 基樹;高倉 範尚
  4. 2008年, 胃静脈瘤出血を契機に発見された膵神経内分泌癌の1例, 日本臨床外科学会雑誌, 見前 隆洋;大田 耕司;棚田 稔;栗田 啓;高嶋 成光;寺本 典弘
  5. 2008年, 幽門側胃切除術後Roux stasis syndromeの検討, 日本消化器外科学会雑誌, 見前 隆洋;二宮 基樹;西崎 正彦;原野 雅生;青木 秀樹;小野田 正;塩崎 滋弘;大野 聡;桧垣 健二;高倉 範尚
  6. 2005年07月01日, 膵癌根治手術における術中放射線照射の効果(肝・胆・膵37, 第60回日本消化器外科学会総会), 日本消化器外科学会雑誌, 塩崎 滋弘;見前 隆洋;守田 陽土;丁田 泰宏;原野 雅生;青木 秀樹;小野田 正;大野 聡;二宮 基樹;高倉 範尚
  7. 2007年08月20日, 43.当院における大細胞神経内分泌癌症例(第46回日本肺癌学会中国・四国支部会), 肺癌, 見前 隆洋;小森 栄作;澤田 茂樹;山下 素弘;栗田 啓
  8. 2007年08月20日, 74.同時性両側肺がんの2手術例(第46回日本肺癌学会中国・四国支部会), 肺癌, 山下 素弘;小森 栄作;澤田 茂樹;見前 隆洋;前田 愛;末久 弘;尾瀬 功;栗田 啓;高嶋 成光;野上 尚之;畝川 芳彦;新海 哲;寺本 典弘;西村 理恵子
  9. 2008年08月01日, 幽門側胃切除術後Roux stasis syndromeの検討, 日本消化器外科学会雑誌, 見前 隆洋;二宮 基樹;西崎 正彦;原野 雅生;青木 秀樹;小野田 正;塩崎 滋弘;大野 聡;桧垣 健二;高倉 範尚
  10. 2008年11月15日, 切除された術前未確診例の検討 : CT検診の臨床診断への影響, 日本呼吸器外科学会雑誌, 沢田 茂樹;小森 栄作;末久 弘;豊崎 良一;見前 隆洋;山下 素弘
  11. 2013年03月05日, YT-12-3(YRA) 臨床病期1A期肺腺癌におけるリンパ管浸潤の意義(YT Young Researcher Award & Traveler's Grant,第113回日本外科学会定期学術集会), 日本外科学会雑誌, 吉屋 智晴;見前 隆洋;津谷 康大;伊富 貴雄太;三隅 啓三;宮田 義浩;中山 治彦;奥村 栄;吉村 雅裕;岡田 守人
  12. 2013年03月05日, YT-12-5(YRA) 病理病期I期の肺腺癌症例においては浸潤径がT因子を反映する(YT Young Researcher Award & Traveler's Grant,第113回日本外科学会定期学術集会), 日本外科学会雑誌, 見前 隆洋;伊富 貴雄太;吉屋 智晴;宮田 義浩;岡田 守人
  13. 2013年03月05日, PS-023-3 臨床病期stageIA肺腺癌における術前補助療法適用の可能性 : 術後遠隔転移再発リスク因子の検討(PS ポスターセッション,第113回日本外科学会定期学術集会), 日本外科学会雑誌, 伊富貴 雄太;津谷 康大;見前 隆洋;吉屋 智晴;宮田 義浩;中山 治彦;奥村 栄;吉村 雅裕;岡田 守人
  14. 2013年03月05日, PS-023-5 より安全な縮小手術のために : リンパ節転移予測因子としての画像的浸潤径とSUVmaxの有用性(PS ポスターセッション,第113回日本外科学会定期学術集会), 日本外科学会雑誌, 三隅 啓三;津谷 康大;伊富貴 雄太;見前 隆洋;吉屋 智晴;宮田 義浩;中山 治彦;奥村 栄;吉村 雅裕;岡田 守人
  15. 2014年03月05日, PS-106-8 シスプラチン誘発性の食思不振とQOL低下に対する六君子湯投与の意義(PS-106 肺 合併症-2・その他,ポスターセッション,第114回日本外科学会定期学術集会), 日本外科学会雑誌, 吉屋 智晴;坪川 典史;笹田 伸介;見前 隆洋;宮田 義浩;岡田 守人
  16. 2014年03月05日, PS-029-8 肺気腫発症の新規機序 : Cell adhesion molecule 1のshedding亢進による細胞内ドメインの産生(PS-029 肺 基礎-1,ポスターセッション,第114回日本外科学会定期学術集会), 日本外科学会雑誌, 見前 隆洋;伊藤 彰彦;萩山 満;坪川 史典;笹田 伸介;吉屋 智晴;宮田 義浩;岡田 守人
  17. 2014年03月05日, VSY-6-1 原発性肺癌に対するロボット手術の初期経験(VSY-6 ビデオシンポジウム(6)Robotic Surgeryによる呼吸器外科施術,第114回日本外科学会定期学術集会), 日本外科学会雑誌, 宮田 義浩;吉屋 智晴;見前 隆洋;笹田 伸介;三隅 啓三;伊富 貴雄太;坪川 典史;岡田 守人
  18. 2012年, Upregulation of Notch2 and Six1 is associated with progression of early-stage lung adenocarcinoma and a more aggressive phenotype at advanced stages, [見前隆洋], 見前隆洋 [著];見前, 隆洋

受賞

  1. 2018年05月18日, 日本呼吸器外科学会学会賞, 特定非営利活動法人 日本呼吸器外科学会
  2. 2011年, 日本胸部外科学会優秀論文賞, 特定非営利活動法人 日本胸部外科学会

外部資金

競争的資金等の採択状況

  1. 科学研究費助成事業(基盤研究(C)), 接着分子CADM1抗体-MMAE複合体を用いた悪性胸膜中皮腫の新規治療開発, 2023年, 2025年
  2. 科学研究費助成事業(基盤研究(C)), 接着分子CADM1抗体-MMAE複合体を用いた悪性胸膜中皮腫の新規治療開発, 2023年, 2025年
  3. 科学研究費助成事業, 肺腺癌のATP関連がん代謝型Glycolysis/OXPHOS評価と薬物耐性克服, 2018年
  4. 広島大学 サタケ基金 平成30年度研究助成金, 2018年
  5. 科学研究費助成事業(研究活動スタート支援), 肺腺癌のATP関連がん代謝型Glycolysis/OXPHOS評価と薬物耐性克服, 2018年, 2019年
  6. 科学研究費助成事業(基盤研究(C)), 肺腺癌のATP代謝経路を標的とした新規治療戦略の開発, 2020年, 2022年